Healthcare
Live Price
Offline$3.85
-4.35% today
Window Change
-47.69%
Window
Jan 21, 2026 โ Jun 15, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 101 bars ยท Jan 21, 2026 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pulsenmore Ltd. Ordinary Shares (PLSM) is a Healthcare stock with a market cap of $60.00M and listed on NASDAQ. The stock last traded around $3.85 and down 47.7% across the available one-year price window (Jan 21, 2026 โ Jun 15, 2026). Baseline metrics include revenue growth of +1409.5%, EPS growth of -57.3%, a dividend yield of 0.0%. What stands out right now is revenue +1409.5%, EPS -57.3%, free cash flow -250.7% with operating margin -30.4% and ROIC -13.1%. Valuation is more restrained than many high-expectation growth names at price/sales 1.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PLSM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+1409.5% vs +7.6% peer median
Operating Margin
Below sector median
-30.4% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at +1409.5% and EPS is at -57.3%, with operating margin around -30.4%.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PLSM
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
PLSM Max Drawdown
-54.89%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for PLSM and SPY.

Company Overview
Pulsenmore Ltd. Ordinary Shares
NASDAQ Global Market
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening in Israel and Europe. The company offers Pulsenmore home ultrasound system, a handheld ultrasound cradle dock with the patient's smartphone; mobile app for uploading images to the cloud for review; and clinician dashboard for clinician to review a stored video or guide a scan in real-time. The company was incorporated in 2014 and is based in Omer, Israel.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.